Radiopharmaceuticals Market

50 %
50 %
Information about Radiopharmaceuticals Market
News-Reports

Published on July 24, 2014

Author: rohitbhisey

Source: authorstream.com

PowerPoint Presentation: USD 1 05 9 5 T r a n s p a r e n c y Ma r k e t R e s e a r c h R a d i o pharmaceut i c a l s M a rket i s gro w i ng at a CA GR of 18.3% fr o m 2 0 13 to 2 0 1 9 . B y T ran s parency Market R e s earch. S i n g l e U s e r L i c e n se : USD 4 59 5 Mu l t i U s e r L i c e n se : USD 7 59 5 C o rp o r a t e U se r L ic e n s e : P u bl i s h e d D a t e 2 0 - F e b- 2 0 1 3 1 2 7 P age R e p o rt Re q u e s t S ample Bu y No w P r e ss R e l e a s e R a d i op h a r mac e ut i ca l s Market i s gro w i ng at a CA GR of 18.3% f r om 2013 to 201 9 . B y T ranspar e ncy M arket R e s earch. T ra n s p are n cy Ma r ket Re s ea r ch S t a t e T owe r , 90, S t a t e S t ree t , S u i t e 7 00. Al b an y , NY 1 22 0 7 U n i t ed S t a t es ww w .t rans p arencymar k e t research . com sa l es@ t ranspa r encymarke t re s earch . com PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket R a d i o ph a r m ac eut i ca l s M a r k et w a s v al ued a t a pp r o x i m a te l y U S D 3.8 b i l l i o n i n 2013 a nd i s e xpe c ted to r e ac h U S D 12.2 b i lli o n by 2019 a t a C A GR o f 18.3% f r o m 2013 to 2019. N o rth Amer ic a l e d the g l o b a l r a d i o ph a r m a c eu t ic a l s m a r k et w i th the h i g he s t m a r k et s h a r e a s C a n a da c o nt i nues to b e the l a r g e s t e xp o rter o f ur a n i um a nd n u c l e a r te c hn o l o gy, f o r m i ng t he b ac kb o ne o f nu c l e a r me d i c i ne a nd i m a g i ng s tud i e s . Br o w s e t h e f ul l r e p o rt at h tt p:/ / ww w . t ra n s par e n cymar k et r e s ea rc h .c o m/rad i o p h armac e u t ical s -mar k e t . h t ml The m a r k et i s e x p e c ted to g r o w a t a C A GR o f 18. 3 % o w i ng to t r eme n d o us r e s e a r c h a nd te c hn o l o g i ca l dev e l o pments o cc u r r i ng w o r l dw i d e a nd the i n c r e as i ng a w a r ene s s a b o ut n u c l e a r med i ci ne a nd m o l e c u l a r i m a g i n g p r oc ed u r e s . The r a d i o ph a r m a c eut i ca l s m a r k et i s s tu d i ed b as ed o n en d -u s er g r o up s , me d ic a l i so t o pe s , a p p li ca t i o ns a nd g e o g r a ph y . T e c hnet i um ( T c -99m) i s the m o s t w i d e l y u s ed r a d i o i so t o pe f o r m ed i ca l a pp li ca t i o n s . T h e m a jo r i ty o f the a p p li ca t i o n m a r k et f o r r a d i o ph a r m a c eut i ca l s i s c o n s t i tuted b y the d i a g n o s i s m a r k et, a nd the ther a p e ut i c a p p li c a t i o n s egment i s e x pe c ted to g r o w a t the f as te s t g r o wth r a te f r o m 2012 to 2018. The g l o b a l m a r k et f o r g e ner a t o rs f o r r a d i o ph a r m ac eut i ca l s w a s v al ued a t o ver U SD 200 m i l l i o n i n 2011 a nd i s e x p e c ted to g r o w a t a he a l t hy C A GR f r o m 2012 to 2018. T h e m a r k et c u r r ent l y c o n s i s ts on l y o f T c -99m g e ner a t o r s ; n ewer ge n er a t o rs f o r m o l e c u l es l i k e R ub i d i um ( R b-82), G a ll i um (G a -67) a nd Yttr i um ( Y -90) a r e e xpe c ted to enter the m a r k et i n the n e xt few ye a r s . T h e s e a r e e x p e c ted to e x h i b i t h i gh d ou b l e d i g i t g r o wth r a tes dur i n g the f o r e ca s t pe r i o d. K ey p l a yers i n th i s m a r k et i n c l u de C o v i d i en P l c , No r d i o n I n c ., L a ntheus Me d ic a l I m a g i ng a nd IB A G r o up, a m o ng o ther s . The m a r k et i s h i gh l y fr a gmen t ed w i th l e a d i n g g l o b a l h e a l th c a r e co mp a n i es o ffer i n g a w i de r a nge o f d i a gn o s t i c a nd ther a peut i c r a d i o ph a r m ac eut i ca l s . The s tudy p r e s ents a c o mp r ehen s i ve a s s e ss ment o f the s t a k eh o l d er s tr a te g i e s , w i nn i n g i mper a t i ves f o r them by s egm e nt i ng t h e r a d i o ph a r m a c eu t ic a l s m a r k et a s b e lo w : T ransparency Market R es e arch 2 RE P O R T D ESCRIPT I O N PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket R a d i o ph a r m ac eut i ca l s M a r k et by G e ner a t o r T ypes M o -99/ T c -99m g e ner a t o r S r -82/ R b-82 g ener a t o r Ge-68/ Ga -68 ge n er a t o r S r -90/ Y - 90 g ener a t o r W -188/ R e-188 g e ner a t o r R a d i o ph a r m ac eut i ca l s M a r k et by E nd- Us ers H os p i t a l s & Me d ic a l C enters D i a gn os t i c Centers R a d i o ph a r m ac eut i ca l s M a r k et by Ap p li ca t i o ns D i a gn os i s D i a gn os i s by T e c hn i q ue S P E CT T e c hnet i um ( T c -99m) Th a l l i um (T I -201) G a ll i um (G a -67) I o d i ne ( I -123) R he n i um ( R e-186) Yt t r i um ( Y -90) O t h e r s P E T T ransparency Market R es e arch 3 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket F l u d e o xyg l u cos e (18 F -FDG) R ub i d i um ( R b-82) O t h e r s (C a rb o n-11 c h o li n e, N i t r o ge n -13 a m m o n i a ) D i a gn os i s by I nd i ca t i o ns O n co l o gy C a r d i o v asc u l a r O t h e r s ( N eu r o l o g ic a l , Thy r o i d, G a s t r o i nte s t i n al ) Ther a py Sy s tem i c O n co l o gy I o d i ne ( I -131) Yt t r i um ( 90 Y ) S a m a r i um (S m -153) S t r o nt i um (89Sr) R he n i um (186 R e) L utet i um ( L u -177) E r b i um (169 E r) O t h e r s O t h e r s (C a r d i o l o gy, N eu r o l o gy) R a d i o ph a r m ac eut i ca l s M a r k et by Ge o gr a phy N o rth Amer i c a E u r o pe A s i a - P ac i f i c T ransparency Market R es e arch 4 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket R e s t o f the W o r l d ( R o W) F o r Samp l e R e p o rt V i s it O n : http : / / ww w . transparencymar k etresearch . com / samp l e / samp l e . php?f l ag= S & rep_ i d=2 1 3 C h a p ter 1 Int r o d u c t i on 1 . 1 Re p o r t De s cri p t i on 1 . 2 M ar k et S e g ment a t i on 1 . 3 Re s e a rc h M eth o d o lo g y C h a p ter 2 E x e c ut i ve Sum m ar y C h a p ter 3 G l o b a l R a d i o p h a r m ac eut i cal s M ar k et Ove r v i ew 3 . 1 Ove r v i ew 3 . 2 M ar k et D ri ve r s 3 . 2 .1 R a d io ph ar m ac eut i c al - B a s ed C a n c er The ra p y 3 . 2 .2 G r o wi ng Pr e f e r en c e F or D i s e a s e - T ar g et e d The r a p y 3 . 2 .3 In cr e a s i ng A w a r en e s s O f A c c u r a te D ia g n o s i s T ransparency Market R es e arch 5 T ABLE O F C O NTENT PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 3 . 2 .4 Ex p a n d i ng M o l e c u l a r Im a g i ng A pp li c a t i o n s 3 . 3 M ar k et R e s t r a i nts 3 . 3 .1 St ric t Re g u la to r y G ui d e li nes F or Pr o d u c t i on, Sto ra g e a nd U s a g e 3 . 3 .2 W o rl dw i d e Su pp l y Sho r t a g e s 3 . 3 .3 Pr i c e Se n s i t i v i ty A nd C om p et i t i ve A l te r n a t i v e s 3 . 4 M ar k et O pp o r tun i t i es 3 . 4 .1 In cr e a s i ng Dem a nd F or Acc u ra te D ia g no s i s a nd T r e a tment, P a r t ic u la r l y In E m e r g i ng M ar k ets 3 . 4 .2 R a d io ph ar m ac eut i c al - B a s ed P e r s on a li zed The ra p y C h a p ter 4 M ar k et Defin i t i on & Su p p l y C h ai n A n a l y s i s 4 . 1 M ar k et Defin i t i on 4 . 2 R a d i o p h a r m ac eut i ca l Pr o d u c t i on : A G lo ba l P e r s p e c t i ve 4 . 3 Su pp l y C h a i n A n al y s i s C h a p ter 5 G l o b a l R a d i o p h a r m ac eut i ca l Gene ra to r s M ar k e t 5 . 1 Ove r v i ew 5 . 1 .1 G lo ba l R a d i o p h ar m ac eut i c a l Gene r a to r s M ar k et, By Revenue, 2 0 1 0 - 2 0 1 8 (USD Mil l i on) 5 . 2 M o - 9 9/ T c -99 m Gene r a to r s 5 . 3 S r -8 2 / R b- 8 2 Gene ra to r s 5 . 4 Ge - 6 8 / G a -67 , 6 8 Gene ra to r s T ransparency Market R es e arch 6 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 5 . 5 S r -9 0 / Y - 9 0 Gene ra to r s 5 . 6 W - 1 8 8 / R e -1 8 8 Gene ra to r s C h a p ter 6 G l o b a l R a d i o p h a r m ac eut i cal s M ar k et, By E n d- U s er G r ou p s 6 . 1 Ove r v i ew 6 . 1 .1 G lo ba l R a d i o p h ar m ac eut i c al s M ar k et By E nd U s e r s , By Revenue, 2 0 1 0- 2 0 1 8 (USD M illi on) 6 . 2 H o sp i t al s a nd M e d ic a l C ente r s 6 . 2 .1 G lo ba l R a d i o p h ar m ac eut i c al s M ar k et By E nd U s er G r ou p s : H o sp i t al s a nd M e d ic a l C ent r e s , 2 0 1 0 – 2 0 1 8 (USD M illi on) 6 . 3 Out p a t i ent D ia g no s t i c C ente r s 6 . 3 .1 G lo ba l R a d i o p h ar m ac eut i c al s M ar k et By E nd U s er G r ou ps : D ia g n o s t i c C ent r e s , 2 0 1 0 – 2 0 1 8 (USD M illi on) C h a p ter 7 G l o b a l R a d i o p h a r m ac eut i cal s M ar k et, By A pp lica t i o n s 7 . 1 Ove r v i ew 7 . 2 R a d i o p h a r m ac eut i cal s F or D i a g n o s i s 7 . 2 .1 Ove r v i ew 7 . 2 .2 R a d io ph ar m ac eut i c al s F o r D ia g no s i s , By T e c hn i q ue 7 . 2 .2 . 1 S i n g l e - P ho t on E m is s i on C om p ut e d T omo g ra p hy ( S P EC T) 7 . 2 .2 . 1 .1 C om p a r a t i ve A n al y s i s : S PEC T R a d i o i s ot o p es M ar k et, 2 0 1 1 & 2 0 1 8 (%) T ransparency Market R es e arch 7 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 7 . 2 .2 . 1 .2 T e c hnet i um ( T c - 9 9 m) 7 . 2 .2 . 1 .3 Th a lli um (T l -2 0 1 ) 7 . 2 .2 . 1 .4 G al l i um (G a -6 7 ) 7 . 2 .2 . 1 .5 I o d i ne (I - 1 2 3 ) 7 . 2 .2 . 1 .6 Rhen i um (R e -1 8 6 ) 7 . 2 .2 . 1 .7 Y tt ri um ( Y - 9 0 ) 7 . 2 .2 . 1 .8 Othe r s 7 . 2 .2 . 2 P o s i t r on E m i ss i on T omo g ra p hy ( PE T) 7 . 2 .2 . 2 .1 C om p a r a t i ve A n al y s i s : PE T R a d i o i s o t o p e s M ar k et, 2 0 1 1 & 2 0 1 8 ( % ) 7 . 2 .2 . 2 .2 Fl u d e o x y g l u c o s e ( 1 8 f - F DG) 7 . 2 .2 . 2 .3 Ru b i d i u m ( R b- 8 2 ) 7 . 2 .2 . 2 .4 Othe r s ( C a r b o n -1 1 C ho l i ne, N i t ro g en 1 3 A mmon i a ) 7 . 2 .3 R a d io ph ar m ac eut i c al s F o r D ia g no s i s , By In d i c a t i ons 7 . 2 .3 . 1 On c o l o g y 7 . 2 .3 . 2 C ar d i ov a s c u l a r 7 . 2 .3 . 3 Othe r s ( Neu r o lo g i c al , Thy r o i d , G a s t r o i nt e s t i n al ) 7 . 3 R a d i o p h a r m ac eut i cal s F or The r a p y 7 . 3 .1 Ove r v i ew 7 . 3 .2 On c o lo g y (Sy s t em i c The r a p y ) 7 . 3 .2 . 1 C om p a r a t i ve A n al y s i s : S y s tem i c The ra p y R a d i o i s o t o p e s M ar k et, 2 0 1 1 & 2 0 1 8 (%) T ransparency Market R es e arch 8 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 7 . 3 .2 . 2 Io d i ne ( I - 1 3 1 ) 7 . 3 .2 . 3 Y tt ri u m ( Y - 9 0 ) 7 . 3 .2 . 4 S a m ar i um (S m -1 5 3 ) 7 . 3 .2 . 5 St r ont i um (S r - 8 9 ) 7 . 3 .2 . 6 Rhen i um ( 1 8 6 Re) 7 . 3 .2 . 7 Lutet i um - 1 7 7 (L u -1 7 7 ) 7 . 3 .2 . 8 Er b i um -1 6 9 ( 1 69 Er ) 7 . 3 .2 . 9 Othe r s 7 .3 . 3 Other A pp lica t i ons In The r a p y ( Car d i o l o g y , Neu r o lo g y) 7 . 4 The r a no s t ic s C h a p ter 8 G l o b a l R a d i o p h a r m ac eut i cal s M ar k et, By Ge o gr a p hy 8 . 1 Ove r v i ew 8 . 2 No r th A me r i c a 8 .2 . 1 No r th A me ri c a R a d i o p h ar m ac eut i c al s M ar k et - D ia g no s i s a nd Sy s tem i c The r a p y , 2 0 1 0 - 2 0 1 8 (USD M illi on) 8 .2 . 2 No r th A me ri c a D ia g no s i s R a d i o p h a r m ac eut i cal s M ar k et 2 0 1 0- 2 0 1 8 (USD Mil l i on) 8 . 3 E u ro p e 8 .3 . 1 E u r o p e R a d io ph ar m ac eut i c al s M ar k e t- D ia g n o s i s a nd Sy s t em i c The r a p y , 2 0 1 0- 2 0 1 8 (USD M illi on) 8 .3 . 2 E u r o p e D ia g n o s i s R a d i o p h ar m ac eut i c al s M ar k et 2 0 1 0 - 2 0 1 8 ( USD M illi on) T ransparency Market R es e arch 9 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 8 . 4 A s ia - P a c i fic ( A p ac ) 8 .4 . 1 A s ia - P aci f i c R a d i o p h ar m ac eut i c al s M ar k e t - D ia g no s i s a nd Sy s tem i c The r a p y , 2 0 1 0 - 2 0 1 8 (USD M illi on) 8 .4 . 2 A s ia - P aci f i c D ia g no s i s R a d i o p h ar m ac eut i cal s M ar k et 2 0 1 0- 2 0 1 8 (USD M illi on) 8 . 5 Re s t of the W o rl d (Ro W ) 8 .5 . 1 RoW R a d io ph ar m ac eut i c al s M ar k e t - D ia g no s i s a nd Sy s tem i c The r a p y , 2 0 1 0- 2 0 1 8 (USD M illi on) 8 .5 . 2 RoW D ia g no s i s R a d i o p h ar m ac eut i c al s M ar k et 2 0 1 0 - 2 0 1 8 ( USD M illi on) C h a p ter 9 M ar k et Sh ar e A n al y s i s By K ey P l a y e r s 9 . 1 R a d i o p h a r m ac eut i cal s M ar k et 9 . 2 Gene r a to r s M ar k et C h a p ter 1 0 Re c omme n d a t i o n s 1 0 .1 I d ent i f i ca t i on a nd E l i m i n a t i on Of B ar r i e r s 1 0 .2 Deve lo p ment of T ot a l So l ut i ons 1 0 .3 Inve s t i ng i n E me r g i ng M ar k e ts 1 0 .4 E nte ri ng M o n o p o l y M ar k e ts C h a p ter 1 1 C om p a ny Pr ofi l es 1 1 .1 C a r d i n a l H e al th In c . T ransparency Market R es e arch 10 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 11 . 1 .1 C o m pa ny Ove r v i e w 11 . 1 .2 Fi n a n c i a l Ove r v i e w 11 . 1 .3 Bu s i n e s s S t r a te g i e s 1 1 .1 . 3 .1 M e r g e r s a nd A c q u i s i t i o n s 1 1 .1 . 3 .2 E x te r n a l F un d i ng 1 1 .1 . 3 .3 In c o rp o r a t i on o f A d v a n c e d T e c hno l o g i e s to S u pp o r t B u s i ne s s D eve l o p ment 11 . 1 .4 Pr o d u c t P o r t f o li o 11 . 1 .5 R e c ent Deve l o p men t s 1 1 .2 C ov i d i en Pl c 11 . 2 .1 C o m pa ny Ove r v i e w 11 . 2 .2 Pr o d u c t P o r t f o li o 11 . 2 .3 Fi n a n c i a l Ove r v i e w 11 . 2 .4 S t r a te g i c Ove r v i ew 1 1 .2 . 4 .1 M e r g e r s a nd A c q u i s i t i o n s 1 1 .2 . 4 .2 Ap p r ov a l s 11 . 2 .5 R e c ent Deve l o p men t s 1 1 .3 GE He al th c ar e 11 . 3 .1 C o m pa ny Ove r v i e w 11 . 3 .2 Pr o d u c t P o r t f o li o 11 . 3 .3 Fi n a n c i a l Ove r v i e w T ransparency Market R es e arch 11 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 11 . 3 .4 S t r a te g i c Ove r v i ew 1 1 .3 . 4 .1 M e r g e r s a nd A c q u i s i t i o n s 11 . 3 .5 R e c ent Deve l o p men t s 1 1 .4 IBA G r o u p 11 . 4 .1 C o m pa ny Ove r v i e w 11 . 4 .2 Fi n a n c i a l Ove r v i e w 11 . 4 .3 Pr o d u c t P o r t f o li o 1 1 .5 L a ntheus M e d ica l Im a g i ng 11 . 5 .1 C o m pa ny Ove r v i e w 11 . 5 .2 Fi n a n c i a l Ove r v i e w 11 . 5 .3 Bu s i n e s s S t r a te g i e s 1 1 .5 . 3 .1 R i g o r ous R e s e arc h a nd Deve lo p ment In i t i a t i ves 1 1 .5 . 3 .2 S e l l i ng Gene ri c Pr o d u c ts t o M ai nt a i n M ar k et Sh ar e 11 . 5 .4 Pr o d u c t P o r t f o li o 1 1 .5 . 4 .1 R e c ent Deve l o p men t s 1 1 .6 M on r ol Nu cl e a r Pr o d u c t s , In c . 11 . 6 .1 C o m pa ny Ove r v i e w 11 . 6 .2 Pr o d u c t P o r t f o li o 11 . 6 .3 S t r a te g i c Ove r v i ew 1 1 .6 . 3 .1 M e r g e r s a nd A c q u i s i t i o n s T ransparency Market R es e arch 12 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 1 1 .6 . 3 .2 C o lla b o ra t i ons 11 . 6 .4 R e c ent Deve l o p men t s 1 1 .7 N o r d i on, In c . 11 . 7 .1 C o m pa ny Ove r v i e w 11 . 7 .2 Pr o d u c t P o r t f o li o 11 . 7 .3 Fi n a n c i a l Ove r v i e w 11 . 7 .4 S t r a te g i c Ove r v i ew 1 1 .7 . 4 .1 C ont rac ts a nd A g r eemen t s 1 1 .7 . 4 .2 D i v e s t i tu r e 11 . 7 .5 R e c ent Deve l o p men t s 1 1 .7 . 5 .1 N ew Pr o d u c t L a u n c h 1 1 .8 NTP R a d i o is ot o p es ( P ty) L t d 11 . 8 .1 C o m pa ny Ove r v i e w 11 . 8 .2 Fi n a n c i a l Ove r v i e w 11 . 8 .3 Bu s i n e s s S t r a te g i e s 1 1 .8 . 3 .1 M e d i a C a m p ai g ns a s a B ra nd M a n ag ement T ool 1 1 .8 . 3 .2 B u s i ne s s E xp a n s i on th r ou g h P a r tne r s h ip s , C o l l a b o ra t i ons a nd All i a n c es 11 . 8 .4 Pr o d u c t P o r t f o li o 11 . 8 .5 R e c ent Deve l o p men t s 1 1 .9 P o la tom T ransparency Market R es e arch 13 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 11 . 9 .1 C o m pa ny Ove r v i e w 11 . 9 .2 Fi n a n c i a l Ove r v i e w 11 . 9 .3 Bu s i n e s s S t r a te g i e s 1 1 .9 . 3 .1 M ai nt ai n i ng a n E x te n s i ve Net w o r k of D i s t ri b uto r s 11 . 9 .4 Pr o d u c t P o r t f o li o 11 . 9 .5 R e c ent Deve l o p men t s 1 1 .10 P o s i t r on C o r p o ra t i on 11 . 10 . 1 C om p a ny Ove r v i ew 11 . 10 . 2 Pr o d u c t P o r t f o li o 11 . 10 . 3 Fi n a n c ia l Ove r v i ew 11 . 10 . 4 St ra te g i c Ove r v i ew 11 . 10 . 4 .1 C ont rac ts a nd A g r eements 11 . 10 . 4 .2 C o lla b o ra t i o n s 11 . 10 . 5 Re c ent Deve lo p ments 11 . 10 . 5 .1 G ra nts a nd L ic en s e s 11 . 10 . 5 .2 In c ent i ves 1 1 .11 S i emens He al th c ar e 1 1 . 1 1 .1 C o m pa ny Ove r v i e w 1 1 . 1 1 .2 Fi n a n ci a l Ove r v i e w 1 1 . 1 1 .3 B u s i ne s s S t r a t e g i es T ransparency Market R es e arch 14 PowerPoint Presentation: R a d i op h a r mac e ut i ca l s M a rket 1 1 . 1 1 .3 . 1 Inve s t i ng In E me r g i ng Ec onom i es 1 1 . 1 1 .3 . 2 R i g o r o u s R e s e a rc h a nd Deve l o p ment In i t ia t i v e s 1 1 . 1 1 .3 . 3 I d ent i f y i ng K e y G r o w th A r e a s a nd D e te r m i n i ng Sho r t T e r m Go al s ( A g en d a 2 0 1 3 ) 1 1 . 1 1 .3 . 4 M ai nt a i n i ng A n E x ten s i ve Su p p li e r s N e t w o r k 1 1 . 1 1 .4 Pro d u c t P o r t f o li o 1 1 .1 1 . 5 Re c ent Deve lo p ments T r a n s p a r e n c y Ma r k e t R e s ea r ch is a ma r k e t i n t e lli g e n ce c o m pa n y p r ov i d i n g g l o ba l b u si n e ss i n f o r m a tion r e p orts a n d s e rvi c e s. O u r e x cl u sive b l en d of q u an ti t a tive f o r e c a s t i n g a n d t r e nd s a na lysis p r ovi d e s forw a r d - looki n g i n si gh t for t h o u s a n d s of d e cision m a k e rs. W e a r e p rivi l e g e d w ith h i gh ly e x p e r i e n c e d t ea m of Ana ly s ts, R e s e a r c h e rs an d Co n s u lt a n ts, w h o u se p r o p ri e t a ry d a ta s o u r c e s a n d v a rio u s tools an d t e c h n i qu e s to g a t h e r, a n d ana l y z e i n f o r m a tio n . O u r b u si n e ss of f e ri n g s r ep r e s e n t t h e l a t e st a n d t h e m ost r e li a b l e i n fo r ma ti o n i nd is p e n s ab le for bu si n e sses to s u s t a in a c o m p e titive e dg e . C ont a c t: T r a n s p a r e n c y Ma r k e t R e s ea r ch 9 0 S t a te S t r ee t, S u ite 7 0 0 , A l b an y NY - 1 2 2 0 7 U n it e d S t a t e s T e l : + 1 -5 1 8 -6 1 8 -1 0 3 0 US A - C an a d a T oll F r e e 8 6 6 -5 5 2 - 3 4 5 3 E m a i l : s a l e s@ t r a n s p a r e n c y ma r k et r e s ea r c h .c o m W e b sit e : h t t p :/ / ww w .t r an s pa r e n c yma r k e t r e s e a r c h .c om / T ransparency Market R es e arch 15 Ab o u t U s

Add a comment

Related presentations

Related pages

Nuclear Medicine / Radiopharmaceuticals Market by ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters ...
Read more

Radiopharmaceuticals Market - Global Segments and ...

Radiopharmaceuticals Market (Generators, PET & SPECT radioiosotopes, Technetium-99m, Gallium-67, Iodine-123, 18F-FDG, Rubidium-82, Yttrium-90 and others ...
Read more

Global Radiopharmaceuticals Market Outlook 2020 - Research ...

1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals ...
Read more

Radiopharmaceuticals Market - Global Industry Analysis ...

Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018. ID: 2422082; February 2013; Region: Global; 119 Pages
Read more

Nuclear Medicine/Radiopharmaceuticals Market worth $6.96 ...

The report “Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha ...
Read more

Radiopharmaceuticals - MarketResearch.com: Market Research ...

Radiopharmaceuticals This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: Diagnostic ...
Read more

Radiopharmaceuticals Market Trends

The global market for Radiopharmaceuticals is projected to reach US$6 billion by 2020, driven by the growing mainstream interest in nuclear medicine, and ...
Read more

Radiopharmaceuticals (MCP-1889) - Global Industry Analysts ...

Research Abstract . This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Segments: Diagnostic ...
Read more

Radiopharmaceuticals: Market Research Report

Radiopharmaceuticals: Market Research Report. Date: January 3, 2015 Pages: 274 Price: US$ 4,950.00 ID: R6F15184084EN This report analyzes the ...
Read more

Market Research in the Healthcare Field with Expertise in ...

Market Research in the Healthcare Field with Expertise in Medical Imaging and Radioisotopes: ... The U.S. Market for SPECT and PET Radiopharmaceuticals.
Read more